3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Lexiscan: new trials by email Literature Review of Lexiscan trials Research Report on Lexiscan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects Regadenoson, Placebo - Healthy Volunteers | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 36 | 2013-05-01 | 2013-08-30 |
| Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia adenosine, regadenoson - Coronary Artery Disease | Phase 1 | Completed | St. Louis University | 46 | 2010-07-01 | 2017-06-23 |
| Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease Lexiscan - Sickle Cell Disease | Phase 1 | Completed | Dana-Farber Cancer Institute | 39 | 2010-04-01 | 2014-03-07 |
Anemia, Sickle Cell (1) · Coronary Artery Disease (1)
Astellas Pharma Global Development, Inc. (1) · Dana-Farber Cancer Institute (1) · St. Louis University (1)
United States (3)
David Nathan, MD (1) · Michael J Lim, MD (1)
PMID 23377438, PMID 26242981, PMID 26607361
1RC2HL101367-01 (1)